Extract notice to the Minister

M-Rivaroxaban

Common name / Subject : rivaroxaban
Name of the manufacturer : Mantra Ph.
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription- Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on March 06, 2025

Subscribe to our newsletter now

Subscription